Kurt A. Gustafson
2011 - Halozyme Therapeutics
In 2011, Kurt A. Gustafson earned a total compensation of $754.4K as Former Vice President and Chief Financial Officer at Halozyme Therapeutics, a 54% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $95,000 |
|---|---|
| Option Awards | $170,788 |
| Salary | $320,850 |
| Stock Awards | $160,080 |
| Other | $7,675 |
| Total | $754,393 |
Gustafson received $320.9K in salary, accounting for 43% of the total pay in 2011.
Gustafson also received $95K in non-equity incentive plan, $170.8K in option awards, $160.1K in stock awards and $7.7K in other compensation.
Rankings
In 2011, Kurt A. Gustafson's compensation ranked 6,667th out of 10,747 executives tracked by ExecPay. In other words, Gustafson earned more than 38.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,667 out of 10,747 | 38th |
Division Manufacturing | 2,418 out of 3,960 | 39th |
Major group Chemicals And Allied Products | 573 out of 1,038 | 45th |
Industry group Drugs | 378 out of 786 | 52nd |
Industry Biological Products, Except Diagnostic Substances | 59 out of 162 | 64th |
Source: SEC filing on April 7, 2014.
Gustafson's colleagues
We found six more compensation records of executives who worked with Kurt A. Gustafson at Halozyme Therapeutics in 2011.
2011
James Shaffer
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2011
Jean Liu
Halozyme Therapeutics
General Counsel
2011
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2011
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2011
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2011
David Ramsay
Halozyme Therapeutics
Chief Financial Officer
News
OmniAb CEO Matthew Foehr's 2023 pay falls 60% to $2.6M
April 26, 2024
OmniAb CEO Matthew Foehr's 2022 pay jumps 26% to $6.7M
May 1, 2023
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2021 pay jumps 110% to $7.8M
April 27, 2022
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2019 pay jumps 21% to $5.7M
April 22, 2020
Spectrum Pharmaceuticals COO Thomas Riga's 2018 pay jumps 388% to $5.3M
April 23, 2019